Kimenai, Dorien M.
Anand, Atul
de Bakker, Marie
Shipley, Martin
Fujisawa, Takeshi
Lyngbakken, Magnus N.
Hveem, Kristian
Omland, Torbjørn
Valencia-Hernández, Carlos A.
Lindbohm, Joni V.
Kivimaki, Mika
Singh-Manoux, Archana
Strachan, Fiona E.
Shah, Anoop S. V.
Kardys, Isabella
Boersma, Eric
Brunner, Eric J.
Mills, Nicholas L. http://orcid.org/0000-0003-0533-7991
Funding for this research was provided by:
HDRUK (HDR-5012)
UK Research and Innovation (ES/T014377/1)
British Heart Foundation (FS/19/17/34172, CH/F/21/90010, RG/20/10/34966, RE/18/5/34216)
Abbott Diagnostics
Siemens Healthineers
Article History
Received: 29 January 2023
Accepted: 5 June 2023
First Online: 19 June 2023
Declarations
:
: This study was approved by University College London Hospital Committee on Ethics of Human Research (reference 85/0938). The HUNT Study was approved by Regional Committee for Medical Research Ethics (REC 2012/859, REC 2016/801) and Norwegian Data Inspectorate Board, and all participants provided informed written consent.
: Not applicable.
: ASVS has received honoraria from Abbott Diagnostics. NLM has acted as a consultant for Abbott Diagnostics, Siemens Healthineers, Roche, and LumiraDx. TO has received speaker and/or consultancy honoraria from Abbott Diagnostics, Bayer Healthcare, CardiNor, Siemens Healthineers, Roche Diagnostics and research support via institution from Abbott Diagnostics, Bayer Healthcare, Novartis, and Roche Diagnostics. The other authors declared no conflicts of interest.